ClinicalTrials.Veeva

Menu

Sphingolipids in Asthma Pathogenesis

P

Peking University

Status

Not yet enrolling

Conditions

Asthma

Study type

Observational

Funder types

Other

Identifiers

NCT06539221
M2023075

Details and patient eligibility

About

The study aims to investigate the relationship between the small molecule metabolite sphingolipids and asthma clinical features and explore its involvement in asthma pathogenesis.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

    1. clinical diagnosis of asthma

Exclusion criteria

    1. Combined with chronic obstructive pulmonary disease, bronchiectasis, pneumonia, obstructive sleep apnea hypopnea syndrome, malignant tumor 2. Combined with acute and chronic respiratory failure 3. Combined with severe cardiovascular disease 4. Pregnant woman.

Trial contacts and locations

1

Loading...

Central trial contact

Chun Chang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems